ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

Society Support Program for Training Cytotechnologists

November 29, 1991

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013

NCI Provides $40 Million To Four Centers For Cancer Communications Research.

June 27, 2003

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995

NCI To Implement Recommendations, Sondik Says

September 2, 1988

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976